Shanghai Eugene Biotech Co., Ltd. is a manufacturer and trading company based in Shanghai, China, specializing in in vitro diagnostic (IVD) reagents and diagnostic tests. Established in 2007, the company operates with 51 to 100 employees and is a subsidiary of China Isotope & Radiation Corporation (CIRC), with its headquarters, Beijing North Institute of Biological Technology (BNIBT), established in 1985. They possess a factory with GMP workshops and advanced R&D and production equipment, including over 10 production lines and an annual output value exceeding US$100 Million. Shanghai Eugene Biotech offers OEM and ODM services, focusing on colloidal gold, CLIA, ELISA, and RIA rapid detection methods. Their extensive product portfolio includes rapid test kits for infectious diseases (such as COVID-19, Monkeypox, HIV, Hepatitis, Syphilis), pregnancy, fertility hormones, tumor markers, and cardiovascular disease markers. They also provide diagnostic test manufacturing equipment like laminators, automated pipetting systems, and guillotine cutters. The company holds ISO 9001, ISO 13485, and CE certifications, with some products registered with the US FDA. With an export percentage of over 90%, Shanghai Eugene Biotech serves international markets across Europe, Asia, Africa, North America, and South America, exporting to over 50 countries.